Fresenius Medical Care AG & Co KGaA - Company Profile
Powered by
All the data and insights you need on Fresenius Medical Care AG & Co KGaA in one report.
- Save hours of research time and resources with
our up-to-date Fresenius Medical Care AG & Co KGaA Strategy Report
- Understand Fresenius Medical Care AG & Co KGaA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Fresenius Medical Care AG & Co KGaA (Fresenius Medical Care), is an integrated dialysis company. It provides dialysis care services and products to individuals with chronic kidney failure. The company develops and manufactures an array of dialysis machines, systems, and disposable products. Fresenius Medical Care also offers care coordination services including pharmacy services, vascular, cardiovascular, and endovascular specialty, non-dialysis laboratory testing, physician, hospitalist and intensivist, and health plan services and urgent care services. The company provides dialysis treatment at its clinics and sells its products to other dialysis service providers. It conducts operations through subsidiaries in Europe, the Middle East, Africa, the Americas and Asia-Pacific. Fresenius Medical Care is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG & Co KGaA premium industry data and analytics
Products and Services
Products | Services |
---|---|
Chronic Hemodialysis: | Laboratory Services |
Cardioprotective Hemodialysis | Perfusion, Autotransfusion and Therapeutic Apheresis Services |
Hemodialyzers and Hemofilters | Dialysis Services |
XYZ | |
XYZ | |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Divestiture | In March, the company sold its dialysis clinic networks in Brazil, Colombia, Chile, and Ecuador to DaVita Inc. for US$300 million. |
2023 | Product Recall | In November, the company recalled its Sanxin Single Use Sterile Syringes due to blood or heparin leaking back or from the syringe. |
2023 | Regulatory Approval | In August, the company secured an approval from the U.S. Food and Drug Administration for Versi HD with GuideMe Software. |
Competitor Comparison
Key Parameters | Fresenius Medical Care AG & Co KGaA | Sanofi | Medtronic Plc | Amgen Inc | Toray Industries Inc |
---|---|---|---|---|---|
Headquarters | Germany | France | Ireland | United States of America | Japan |
City | Bad Homburg Vor Der Hohe | Paris | Dublin | Thousand Oaks | Chuo-Ku |
State/Province | Hessen | Ile-de-France | - | California | Tokyo |
No. of Employees | 112,382 | 87,994 | 95,000 | 26,700 | 48,682 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Michael Sen | Chairman | Executive Board | - | 55 |
Helen Giza | Chief Executive Officer | Senior Management | 2022 | 56 |
Martin Fischer | Chief Financial Officer | Senior Management | 2023 | 46 |
Franklin W. Maddux, M.D. | Chief Medical Officer | Senior Management | 2019 | 66 |
Sara Hennicken | Deputy Chairwoman | Executive Board | - | 43 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward